ASX · CGB.AX
Cann Global Limited
A$0.02A$0.00 (0.0%)
Cann Global Limited’s quoted price sits in the lower half of its reported 52-week range, 27.59% below the high.
Loading market information…
ASX · OVN.AX · AUD
Stock price, earnings
Quote as of Jun 7, 2022, 04:16 AM UTC. Cached market data; not a live quote.
One-year closing-price history · AUD. Historical prices are not a forecast.
Oventus Medical Limited’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Oventus Medical Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Oventus Medical Limited is a medical device enterprise focused on the creation and commercialization of oral appliances designed to alleviate obstructive sleep apnea (OSA) and snoring. The company distributes its solutions across Australia, Canada, and the United States. Key offerings include the O2Vent Optima, a custom 3D-printed nylon oral appliance developed for OSA patients, and ExVent, a valve accessory specifically designed to fit into the O2Vent Optima's airway. Established in 2015, the firm's main office is located in Indooroopilly, Australia.
Latest available per-share figures in AUD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:13 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
A$0.02A$0.00 (0.0%)
Cann Global Limited’s quoted price sits in the lower half of its reported 52-week range, 27.59% below the high.
A$0.02A$0.00 (0.0%)
Opyl Limited’s quoted price sits in the lower half of its reported 52-week range, 38.89% below the high.
A$0.00A$0.00 (0.0%)
Analytica Limited’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
A$0.00-A$0.00 (-50.0%)
Medibio Limited’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
A$0.02A$0.00 (0.0%)
Bod Science Limited’s quoted price sits in the lower half of its reported 52-week range, 11.11% below the high.
A$0.01A$0.00 (0.0%)
Universal Biosensors, Inc.’s quoted price sits in the lower half of its reported 52-week range, 91.25% below the high.
A$0.04A$0.00 (0.0%)
Freedom Care Group Holdings Ltd.’s quoted price sits in the lower half of its reported 52-week range, 82.38% below the high.
A$0.07A$0.00 (0.0%)
Visioneering Technologies, Inc.’s quoted price sits in the lower half of its reported 52-week range, 73.6% below the high.
